Quest Diagnostics (DGX) PT Lowered to $107 at Morgan Stanley
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $234.40 -0.69%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Morgan Stanley analyst Ricky Goldwasser lowered the price target on Quest Diagnostics (NYSE: DGX) to $107.00 (from $120.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quest Diagnostics (DGX) Declares $0.86 Quarterly Dividend; 1.4% Yield
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
